Intranasal dexmedetomidine sedation for EEG in children with autism spectrum disorder

Bibliographic Data

ID15527303
AuthorsArianna De Laurentiis (0009-0001-9520-7666, Istituti di Ricovero e Cura a Carattere Scientifico), Chiara Pastori (0000-0002-9121-5087, Istituti di Ricovero e Cura a Carattere Scientifico, corresponding author), Carmela Pinto (Fondazione IRCCS Istituto Neurologico Carlo Besta), Stefano D’Arrigo (0000-0001-5188-9418, Istituti di Ricovero e Cura a Carattere Scientifico), Margherita Estienne (0000-0002-6769-5631, Istituti di Ricovero e Cura a Carattere Scientifico), Sara Bulgheroni (0000-0002-0905-8810, Istituti di Ricovero e Cura a Carattere Scientifico), Giulia Battaglia (0000-0002-7660-4818, Istituti di Ricovero e Cura a Carattere Scientifico), Marco Gemma (0000-0002-9543-3831, Fondazione IRCCS Istituto Neurologico Carlo Besta)
Year2024
Volume15
Pages1462526-1462526
Publication date2024-10-10
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueFrontiers in Psychiatry (JOURNAL)
Journal identifiersISSN: 1664-0640 • E-ISSN: 1664-0640
PublisherFrontiers Media (PUBLISHER • CH)
DOI10.3389/fpsyt.2024.1462526
PMID39450307
OpenAlexW4403306595
LanguageEN
References cited24

In the light of these results, we can state that In-Dex sedation is safe and reduce EEG failure rate compared to the use of melatonin and hydroxyzine alone, particularly in patients with severe behavioral issues

Anesthesia · Autism · Autism spectrum disorder · Dexmedetomidine · Electroencephalography · Hydroxyzine · Psychiatry · Sedation · Anesthesia and Sedative Agents · Epilepsy research and treatment · Infant Development and Preterm Care · Medicine

Tools

Open DOIOpen Access